Annals of Oncology

News:

Divergent illicit drug policies in Europe
Ann Oncol 9: 1257.
[PDF] [Request Permissions]

Partial consensus about breast and cancer treatment in Florence
Ann Oncol 9: 1257.
[PDF] [Request Permissions]

Cancer targets unmet, while life expectancy falls in Europe
Ann Oncol 9: 1258.
[PDF] [Request Permissions]

What about euthanasia and palliative care in Europe?
Ann Oncol 9: 1258.
[PDF] [Request Permissions]

WHO in search of cancer strategies for the new millennium
Ann Oncol 9: 1258-1259.
[PDF] [Request Permissions]

Awards, appointments
Ann Oncol 9: 1259-1260.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 9: 1260-1261.
[PDF] [Request Permissions]

Book reviews:

M. Alerci

Book review
Ann Oncol 9: 1262.
[PDF] [Request Permissions]

J. Bernier

Book review
Ann Oncol 9: 1268.
[PDF] [Request Permissions]

Editorial:

P. Boyle

Prostate specific antigen (PSA) testing as screening for prostate cancer: The current controversy
Ann Oncol 9: 1263-1264.
[PDF] [Request Permissions]

A. Thomas and W.P. Steward

Gemcitabine - a major advance?
Ann Oncol 9: 1265-1267.
[PDF] [Request Permissions]

Review:

A.C. Lambrechts, L.J. van't Veer, and S. Rodenhuis

The detection of minimal numbers of contaminating epithelial tumor cells in blood or bone marrow: Use, limitations and future of RNA-based methods
Ann Oncol 9: 1269-1276.
[Abstract] [PDF] [Request Permissions]

Debate:

M. J. Barry and Patient Outcomes Research Team for Prostatic Diseases

PSA screening for prostate cancer: The current controversy - a viewpoint
Ann Oncol 9: 1279-1282.
[Abstract] [PDF] [Request Permissions]

D. Svetec and I. M. Thompson

PSA screening - current controversy
Ann Oncol 9: 1283-1288.
[Abstract] [PDF] [Request Permissions]

D.E. Neal and J.L. Donovan

Screening for prostate cancer
Ann Oncol 9: 1289-1292.
[PDF] [Request Permissions]

H. J. de Koning and F. H. Schroder

PSA screening for prostate cancer: The current controversy
Ann Oncol 9: 1293-1296.
[PDF] [Request Permissions]

M. Zappa, S. Ciatto, R. Bonardi, and A. Mazzotta

Overdiagnosis of prostate carcinoma by screening: An estimate based on the results of the Florence Screening Pilot Study
Ann Oncol 9: 1297-1300.
[Abstract] [PDF] [Request Permissions]

Original articles:

C. Tropé, Th. Hogberg, J. Kaern, K. Bertelsen, E. Bjorkholm, K. Boman, A. Himmelmann, G. Horvath, A. Jacobsen, T. Kuoppola, J. Vartianen, B. Lund, M. Onsrud, U. Puistola, T. Salmi, M. Scheistroen, R. Sandvei, E. Simonsen, B. Sorbe, B. Tholander, and R. Westberg

Long-term results from a phase II study of single agent paclitaxel (Taxol®) in previously platinum treated patients with advanced ovarian cancer: The Nordic experience
Ann Oncol 9: 1301-1307.
[Abstract] [PDF] [Request Permissions]

M. Hejna, G.V. Kornek, M. Raderer, J. Valencak, G. Weinländer, W. Fiebiger, J. Miholic, and W. Scheithauer

5-Methyltetrahydrofolate for biochemical modulation of fluorouracil (FU) in patients with advanced colorectal cancer: A randomized phase I—II study of two different FU administration schedules
Ann Oncol 9: 1309-1314.
[Abstract] [PDF] [Request Permissions]

C. Sessa, C. Minoia, A. Ronchi, M. Zucchetti, J. Bauer, M. Borner, J. de Jong, O. Pagani, J. Renard, C. Weil, and M. D'lncalci

Phase I clinical and pharmacokinetic study of the oral platinum analogue JM216 given daily for 14 days
Ann Oncol 9: 1315-1322.
[Abstract] [PDF] [Request Permissions]

K. Mross, W.E. Berdel, H.H. Fiebig, R. Velagapudi, I.M. von Broen, and C. Unger

Clinical and pharmacologic phase I study of Cemadotin-HCI (LU103793), a novel antimitotic peptide, given as 24-hour infusion in patients with advanced cancer: A study of the Arbeitsgemeinschaft Internistische Onkologie (AIO) Phase I Group and Arbeitsgruppe Pharmakologie in der Onkologie und Haematologie (APOH) Group of the German Cancer Society
Ann Oncol 9: 1323-1330.
[Abstract] [PDF] [Request Permissions]

N.I. Weijl, A. Wipkink-Bakker, E.G.W.M. Lentjes, H.M. Berger, F.J. Cleton, and S. Osanto

Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients
Ann Oncol 9: 1331-1337.
[Abstract] [PDF] [Request Permissions]

Clinical case:

J. Andrade Santiago, L. Robles, C. Casimiro, V. Casado, A. Ageitos, M. Domine, L. Estevez, J. Vicente, and F. Lobo

Chylopericardium of neoplastic aetiology
Ann Oncol 9: 1339-1342.
[Abstract] [PDF] [Request Permissions]

Short report:

M. Friedlander, M.J. Millward, D. Bell, R. Bugat, P. Harnett, J.A. Moreno, L. Campbell, C. Varette, V. Ripoche, and L. Kayitalire

A phase II study of gemcitabine in platinum pre-treated patients with advanced epithelial ovarian cancer
Ann Oncol 9: 1343-1345.
[Abstract] [PDF] [Request Permissions]

R. Hitt, D. Castellano, M. Hidalgo, R. Garcia-Carbonero, M. Peña, A. Brandariz, J.M. Millán, J.J. Alvarez Vincent, and H. Cortés-Funes

Phase II trial of cisplatin and gemcitabine in advanced squamous-cell carcinoma of the head and neck
Ann Oncol 9: 1347-1349.
[Abstract] [PDF] [Request Permissions]

P. L. Zinzani, M. Magagnoli, M. Bendandi, G. Fraternali Orcioni, F. Gherlinzoni, P. Albertini, S. A. Pileri, and S. Tura

Therapy with gemcitabine in pretreated peripheral T-cell lymphoma patients
Ann Oncol 9: 1351-1353.
[Abstract] [PDF] [Request Permissions]

Letters to the editor:

K. Nackaerts, M. Daenen, J. Vansteenkiste, A. Van-develde, P. Van Bleyenbergh, and M. Demedts

Hemolytic-uremic syndrome caused by gemcitabine
Ann Oncol 9: 1355.
[PDF] [Request Permissions]

J. Gumà, J. Rubió, C. Masip, T. Alvaro, and J. L. Borrás

Aggressive bowel lymphoma in a patient with intestinal lymphangiectasia and widespread viral warts
Ann Oncol 9: 1355-1356.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.